Health Catalyst, Inc.

Health Catalyst builds cloud-based data and analytics software for healthcare organizations, combining a data platform, analytics applications, and implementation expertise. Its customers use the solution to integrate clinical and operational data, generate insights, and improve financial, operational, and care outcomes across health systems and related healthcare entities.

−35,5 %

−57,2 %

+1,5 %

1.89

1.89

— Health Catalyst, Inc.
%
Technology revenue67% Subscription and platform revenue from cloud data infrastructure and analytics applications, including Health Catalyst Ignite and related software.
Professional services revenue33% Implementation, advisory, and managed services that help clients deploy the platform and realize measurable improvement.

Health Catalyst sells primarily to healthcare providers, especially health systems that need to unify data and improve...

  • Health systems and healthcare providersprimary

    Primary buyers of the platform and applications to manage data, improve workflows, and drive measurable clinical and financial outcomes.

  • Risk-bearing entitiessecondary

    Organizations that need population health, care coordination, and analytics to manage utilization and downside risk.

  • Life science organizationssecondary

    Buy data and analytics capabilities for research, registry, and evidence-generation use cases.

  • Payerssecondary

    Use selected analytics and data tools to support cost, quality, and utilization management.

  • Healthcare technology companiesemerging

    Purchase cybersecurity or data-related solutions in narrower use cases.

The company is primarily U.S.-focused, but it also has a presence in Singapore, the UK, and a small number of other...

  • •United States is the core market and main revenue base
  • •Presence in Singapore and the UK supports international expansion
  • •Other countries are limited and opportunistic in scope
  • •Healthcare provider demand outside the U.S. is a growth option
  • •Geography matters because healthcare workflows and regulation differ by market

Health Catalyst is focused on simplifying its commercial engine, improving retention, and increasing technology ARR...

01
Strengthen and simplify the commercial engineshort-term

Management wants more efficient bookings growth and better conversion in the most differentiated offerings.

02
Complete migration to Health Catalyst Ignitemedium-term

Migrating legacy DOS clients should improve product relevance and eventually support better gross margin and retention.

03
Increase automation and global delivery efficiencymedium-term

Lower operating complexity and better use of global resources should improve scalability and time to value.

04
Expand AI-enabled and IP-driven solutionslong-term

Combining data foundation with expertise and AI can deepen differentiation and support long-term growth.

The business faces intense competition from analytics vendors, EHR companies, point solutions, and homegrown healthcare...

high

Intense competition across healthcare analytics and software

Clients can choose EHR vendors, niche point solutions, or homegrown tools instead of Health Catalyst's platform.

Scope
Pricing, market share, and new bookings
Materiality
high
high

Migration execution risk from DOS to Health Catalyst Ignite

Migration increases technology costs in the near term and can affect gross margin and client satisfaction if delayed.

Scope
Technology revenue and gross margin
Materiality
high
high

Privacy, security, and PHI handling risk

The company processes sensitive healthcare data and must comply with contractual and regulatory obligations.

Scope
Operational continuity, legal liability, reputation
Materiality
high
high

Goodwill impairment risk

Management recorded material goodwill impairment and further declines in stock price or performance could trigger more charges.

Scope
Reported earnings and balance sheet
Materiality
high
medium

Healthcare policy and client budget pressure

Medicaid and research funding reductions can strain customer budgets and delay purchasing decisions.

Scope
Revenue growth and contract timing
Materiality
medium
Revenue recognition for technology subscriptions and professional services
Quarterly revenue and margin volatility
Goodwill impairment
Large non-cash earnings volatility
Contingent consideration from acquisitions
G&A and operating income
Migration-related technology costs
Technology gross margin and adjusted EBITDA

CATALYST PHARMACEUTICALS, INC.

CPRX · Pharmaceutical Preparations

Catalyst Bancorp, Inc.

CLST · Savings Institution, Federally Chartered

Health In Tech, Inc.

HIT · Insurance Agents, Brokers & Service

Elevance Health, Inc.

ELV · Hospital & Medical Service Plans

MEDIFAST INC

MED · Miscellaneous Food Preparations & Kindred Products

SOLIGENIX, INC.

SNGX · Pharmaceutical Preparations

: 28.4.2026